Related Content
Download content relating to this event and topic.
DISCOVERY · INNOVATION · SCALE · From breakthrough science to commercial reality. DACH’s focused end-to-end forum for oligonucleotides and peptides, bringing together the region’s leaders to advance precision therapeutics.
.webp)
.webp)
Oligos & Peptides Confex DACH 2027 (#OPXDACH2027) brings together one of Europe's most important hubs for oligonucelotide and petides innovation and manufacturing, the DACH region plays a critical role in advancing the next generation of precision therapeutics.
From discovery and early development in Germany and Switzerland to innovation, process development and commercial-scale manufacturing, the DACH region plays a critical role in advancing the next generation of precision therapeutics.
#OPXDACH2027 is designed to be a focused, high-value meeting for the people driving progress in the field. Bringing together a carefully curated group of industry leaders, the event combines relevant, practical content with meaningful networking and open discussion — creating the space for real conversations, trusted connections and partnerships that continue beyond the event.


Visit the event page to view more content.
Visit the awards page to view more content.
View the Key Themes for
OPX: Oligos & Peptides Confex 2027 (DACH Edition)
Register today to secure your ticket.
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.






20+ years driving operational transformation in pharma/biotech, optimising E2E processes (S&OP, network design, product launch) through data integration, digital tools, and cross-functional collaboration. Proven success in change management, cost reduction, supplier management, tech transfer leader for drug product (aseptic processes), and M&A integration within complex matrix environments. Focused on building scalable, patient-centric supply chains. Adept at balancing functional priorities with enterprise strategy while influencing stakeholders at all levels. Passionate about leveraging AI and advanced analytics to enhance decision-making and operational agility. Let’s connect to discuss the future of intelligent pharma operations.










Gnana Oli Rajaraman is a bioanalytical expert specialising in preclinical and clinical regulatory sciences. Currently Associate Director at AiCuris, he focuses on assay development for PK and immunogenicity (ADA) across biotherapeutics, ADCs, and oligonucleotides. With a background from The Julius Maximilians University of Würzburg, Gnana has extensive experience managing internal teams and CROs to support successful NDA and CTA submissions through rigorous regulatory compliance.


Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Apply to SpeakSelect the relevant ticket for your organisation.
*Delegate tickets must be purchased under the correct classification.
Biopharma tickets are strictly reserved for professionals employed by pharmaceutical or biopharmaceutical companies that develop, own, or commercialise therapeutic drug products, including organisations with an internal drug pipeline spanning discovery, development, clinical, or commercial stages. This category applies to companies whose primary business is the development or manufacture of drug products, not the provision of enabling technologies, equipment, platforms, or services.
Service, Solution, and Technology Provider tickets apply to all organisations offering services, platforms, technologies, equipment, consultancy, manufacturing services, or commercial solutions to the pharma and biopharma industry. This includes, but is not limited to, CROs, CDMOs, technology and equipment vendors, consultants, suppliers, and solution providers, regardless of scientific or technical focus.
Important Notice
All registrations are reviewed to ensure correct classification. Purchasing an incorrect ticket does not guarantee entry to the event. IMAPAC retains full discretion to deny access, reclassify registrations, and issue an invoice for the price difference required for correct attendance. Incorrect ticket purchases made under an inappropriate classification are not eligible for refunds under any circumstances, including where the registrant chooses not to upgrade or attend.
Super Early Bird Rate : £1,999.00
Use discount code: SEB
(Valid until 25th September 2026)
Early Bird Rate : £2,199.00
Use discount code: EB
(Valid until 6th November 2026)
Registration Open Rate : £2,399.00
Use discount code: RO
(Valid until 18th December 2026)
Classic Rate : £2,599.00
Use discount code: CR
(Valid until 29th January 2027)
Standard Rate : £2,799.00
Applicable to company profiles
(headquartered outside of the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality.
Early Bird Rate : £2,899.00
Use discount code: EBVD
(Valid until 6th November 2026)
Registration Open Rate : £3,299.00
Use discount code: ROVD
(Valid until 18th December 2026)
Classic Rate : £3,599.00
Use discount code: CRVD
(Valid until 29th January 2027)
Standard Rate : £3,899.00
Applicable to company profiles:
Be the first in line!
Register your interest to get access to tickets as soon as they go live.
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Visit the event page to view more content.
Download content relating to this event and topic.
To stay informed about event updates, including date, venue, and agenda, please subscribe to our our official social media channels for real-time updates and announcements.
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Yes, we offer sponsorship and exhibition opportunities for businesses and organisations.
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Don't miss out on unique networking, speaking and sponsorship opportunities.
Scan this QR code using WeChat or WeCom to connect with our team.
FOK YIH KEIT KAETHE
IMAPAC